Novolog Assistance Programs And Sample Options For Diabetes Patients

Introduction

NovoLog® (insulin aspart) injection 100 U/mL is a man-made insulin used to control high blood sugar in adults and children with diabetes mellitus. For patients seeking financial assistance or samples of this medication, Novo Nordisk offers several programs and resources. These include commercial insurance savings programs, a patient assistance program for those who qualify, and a professional platform for healthcare providers to access samples and resources. This article explores the various options available to patients seeking NovoLog samples or financial assistance.

NovoLog Commercial Insurance Savings Programs

For patients with commercial insurance, such as insurance received through an employer, Novo Nordisk offers savings programs that can significantly reduce the cost of NovoLog. According to the available information, eligible individuals may pay as little as $35 per 30-day supply, with maximum savings up to $65 per 30-day supply. Alternatively, patients may pay no more than $99 for up to 24 months of medication.

Important Considerations for Commercial Insurance Programs

• If NovoLog® is not covered by insurance, or if the copay exceeds $100 per 30-day supply, the savings offer works outside of insurance coverage
• When used outside insurance, the offer does not count toward any deductibles
• The savings offer cannot be applied to a patient's true out-of-pocket costs when using insurance benefits

Enrollment Options

Patients can enroll in the NovoLog savings program through multiple channels:

1. Text Enrollment: Individuals can text "SAVE" to 97430 to register and save the Novo Nordisk Savings Offer to their mobile phone. This option is convenient for those who prefer mobile communication. Message and data rates may apply, and patients should check with their mobile service provider. For assistance with text enrollment, patients can text "HELP" to 97430. To unsubscribe, they can text "STOP" to 97430.

2. Online Enrollment: The official NovoLog website provides an option to check insurance benefits and determine potential savings by entering basic information.

3. Spanish Language Support: For Spanish speakers, enrollment assistance is available by calling 1-833-992-3301.

MyInsulinRx™ Program

Novo Nordisk offers an additional savings program called MyInsulinRx™ that provides consistent pricing across their insulin products. With this program, eligible patients may pay $35 for a monthly supply of any combination of Novo Nordisk insulin products. The offer includes up to 3 vials or 2 packs of pens (up to 35 mL) per month. This cost does not apply to any insurance deductible the patient may have.

The MyInsulinRx™ program is available each month throughout the calendar year, providing predictable pricing for patients who regularly use Novo Nordisk insulin products. This program may be particularly beneficial for patients who use multiple insulin products or those who need consistent budgeting for their medication costs.

Novo Nordisk Patient Assistance Program (PAP)

For patients who face significant financial barriers to accessing their medication, Novo Nordisk offers a Patient Assistance Program (PAP) that provides medication at no cost to those who qualify. This program is based on Novo Nordisk's commitment to patients who need financial support.

Key Features of the PAP

• No Cost Medication: Patients approved for the PAP may receive free medication from Novo Nordisk
• No Registration Fees: There is no registration charge or monthly fee for participating in the program
• Spanish Language Support: The program offers Spanish language resources and application options

Eligibility Requirements

To be eligible for the PAP in 2025, applicants must meet specific criteria, though the exact requirements are not detailed in the provided source material. The application process can be completed either online through a step-by-step process or by paper application.

The PAP covers various Novo Nordisk products, including:

• Ozempic® (semaglutide) injection
• RYBELSUS® (semaglutide) tablets
• Victoza® (liraglutide) injection
• Xultophy® 100/3.6
• Fiasp® (insulin aspart) injection
• GlucaGen® HypoKit®
• Levemir® (insulin detemir) injection
• NovoLog® (insulin aspart) injection
• NovoLog® Mix 70/30
• Tresiba® (insulin degludec) injection
• ZEGALOGUE® (dasiglucagon) injection

novoMEDLINK™ Platform

Novo Nordisk provides a professional platform called novoMEDLINK™ that offers healthcare professionals access to various resources, including sample ordering capabilities. When registering with novoMEDLINK™, users gain access to a personalized, curated newsfeed of exclusive content and professional resources across all therapy areas.

Features of novoMEDLINK™

• Sample Ordering: Healthcare providers can order samples for their patients through this platform
• Supply Updates: Users receive information about medication supply status
• Patient Support Materials: The platform includes resources to help support patients using Novo Nordisk medications
• Professional Resources: Access to professional news and educational materials
• Digital Hub: All resources are consolidated in one convenient digital platform

For patients, this platform primarily serves as a resource for healthcare providers rather than a direct consumer sample access point. Healthcare professionals can use novoMEDLINK™ to obtain samples that they may then provide to eligible patients.

ReliOn™ NovoLog® Alternative

For cost-conscious consumers, Novo Nordisk manufactures a private label version of NovoLog® called ReliOn™ NovoLog®, which is sold exclusively at Walmart and Sam's Club. While not a free sample option, this alternative may provide a more affordable way to access the same active ingredient (insulin aspart) as the brand-name product.

ReliOn™ NovoLog® is manufactured by Novo Nordisk but distributed under Walmart's private label, potentially offering a lower price point compared to the brand-name version. This option may be particularly suitable for patients without insurance coverage or those with high deductibles.

Obtaining Samples of Humalog®

While the focus of this article is on NovoLog®, it's worth noting that Novo Nordisk's competitor Eli Lilly offers a samples program for Humalog® (insulin lispro), another insulin product. According to available information, healthcare providers can request samples for Humalog products by completing and submitting an electronic request form.

For patients interested in Humalog®, the process involves working with a healthcare provider who can access the sample request system through official channels. Adverse events or product complaints regarding Humalog® should be reported by calling 1-800-LILLYRX (1-800-545-5979).

Healthcare Provider Resources

Novo Nordisk provides resources specifically designed for healthcare professionals to help them support their patients. These resources include:

• Sample Ordering: Healthcare providers can order samples through platforms like novoMEDLINK™
• Device Training: Educational materials on how to use Novo Nordisk pen devices
• Educational Materials: Resources for patient education about diabetes management
• Product Information: Detailed information about Novo Nordisk products
• Personalized Resource Updates: Tailored information based on specific therapy areas

These resources are primarily targeted at healthcare providers rather than patients directly, though patients may benefit indirectly when their providers have access to comprehensive training and educational materials.

Conclusion

For patients seeking NovoLog samples or financial assistance, Novo Nordisk offers several programs and resources that may help reduce costs or provide access to medication. Commercially insured patients may be eligible for savings programs that reduce the cost to as little as $35 per month, while those without insurance or with significant financial need may qualify for the Patient Assistance Program, which provides medication at no cost. Additionally, the MyInsulinRx™ program offers consistent pricing across Novo Nordisk insulin products.

For healthcare providers, platforms like novoMEDLINK™ offer sample ordering capabilities and comprehensive resources to support patient care. While direct consumer sample access for NovoLog is not clearly detailed in the provided information, these various assistance programs provide multiple pathways to obtaining the medication at reduced or no cost for eligible patients.

Patients interested in these programs should contact Novo Nordisk directly or speak with their healthcare provider about the most appropriate option for their individual situation.

Sources

1. NovoLog® Savings Offer
2. NovoLog® Savings Information
3. Humalog® Sample Information
4. novoMEDLINK™ Platform
5. novoMEDLINK™ Diabetes Resources
6. Novo Nordisk Patient Assistance Program
7. Novo Nordisk Diabetes Samples